Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100050212 | 10005021 | 2 | F | 201403 | 20140325 | 20140312 | 20140331 | EXP | PHHY2014JP029200 | NOVARTIS | 0.00 | NS | Y | 0.00000 | 20140331 | N | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100050212 | 10005021 | 1 | PS | TASIGNA | 1 | ORAL | UNK UKN, UNK | N | 22068 | CAPSULE | |||||||||
| 100050212 | 10005021 | 2 | SS | TASIGNA | 1 | ORAL | 200 MG, DAILY | N | 22068 | 200 | MG | CAPSULE |
Indications of drugs used
| no results found |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100050212 | 10005021 | Oedema | |
| 100050212 | 10005021 | Overdose | |
| 100050212 | 10005021 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |